Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia
Jessica M. Salmon(Peter MacCallum Cancer Centre), Ricky W. Johnstone(Peter MacCallum Cancer Centre)
Cited by 24
Related Papers
New and emerging HDAC inhibitors for cancer treatment
|Journal of Clinical Investigation|2014|1.4k
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
|Cell Reports|2017|297
T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments
|Nature|2016|205